5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as PTPase 1B inhibitors

Details for Australian Patent Application No. 2003224030 (hide)

Owner Novartis AG

Inventors Stams, Travis Mathew; Davies, John William; Jewell, Charles Francis Jr; Wareing, James Richard; Vlattas, Isidoros; Topiol, Sidney Wolf; Sperbeck, Donald Mark; COPPOLA, Gary, Mark; Li, Yu-Chin

Agent Davies Collison Cave

Pub. Number AU-B-2003224030

PCT Number PCT/EP03/03466

PCT Pub. Number WO2003/082841

Priority 60/369,779 03.04.02 US; 60/369,930 03.04.02 US

Filing date 2 April 2003

Wipo publication date 13 October 2003

Acceptance publication date 1 November 2007

International Classifications

C07D 285/10 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5513 (2006.01)

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/369,779 03.04.02 US; 60/369,930 03.04.02 US

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003224030

1 November 2007 Application Accepted

  Published as AU-B-2003224030

28 February 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003224031-Indolylmaleimide derivatives

2003224029-PERSONAL CARE ARTICLE WITH DISTINCT ACTIVE ZONE